The MYOC gene helps make myocilin, a protein active in the eye’s drainage tissue that supports normal fluid flow and eye pressure. If this gene does not work properly, fluid can drain less well, eye pressure may rise, and the optic nerve can be damaged. Certain variants in the MYOC gene are a well-established cause of some inherited forms of open-angle glaucoma, including forms that start young.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or to regulate processes in the body. Some genes carry the directions for making proteins, the parts of cells that do the work. Others mainly guide when certain processes occur, where they happen, and how strongly they are turned on. Together, genes shape how the body grows and operates, and they can affect how you respond to food, stress, or medicines. More about this topic is available in the LearnHub.
Overview
MYOCGene function
What if the gene works
The MYOC gene makes myocilin, a protein found mainly in the eye’s drainage tissue. It helps support normal fluid outflow and steady pressure inside the eye.
Risk
What if the gene does not work
Variants in the MYOC gene are linked to inherited open-angle glaucoma, often starting earlier in life and raising eye pressure. Effects can range from milder to more severe, which may influence when vision changes begin and how much damage develops.
Treatment
What does that mean for your treatment
No MYOC-specific treatment or drug choice is currently established in clinical guidelines; care still follows standard pressure-lowering glaucoma treatment. Research is exploring ways to reduce harmful myocilin buildup or silence the MYOC gene, but these approaches are not part of routine care.
Conditions associated with MYOC
Gene function
What if the gene works
The MYOC gene is especially active in the eye, mainly in the drainage tissue near the front of the eye. It helps make myocilin, a protein released around cells to support their everyday work. This is part of the MYOC gene's normal role in eye fluid drainage and eye pressure balance.
MYOC helps the drainage tissue at the front of the eye support the smooth movement of aqueous humor, the clear fluid inside the eye. This steady flow helps keep eye pressure in a healthy range.
The myocilin protein is released outside cells and becomes part of the material around them. It helps cells stay connected to their surroundings and supports the shape and upkeep of the drainage pathway.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the MYOC gene's function often depends on whether the DNA change makes the myocilin protein fold incorrectly or cuts it short. Many disease-causing variants in the MYOC gene lead to a misfolded protein that is not released properly, builds up inside cells in the eye's drainage tissue, and causes cell stress. More disruptive variants can have a larger functional effect and are often linked to earlier-onset or more marked glaucoma, while milder variants may leave some protein function intact.
How variants are linked to conditions
Pathogenic variants in the MYOC gene can cause juvenile open-angle glaucoma and are also found in some families with adult primary open-angle glaucoma. In practice, MYOC gene variants linked to glaucoma are most often associated with an inherited form of eye disease that may run through several generations. When a disease-causing MYOC variant is identified in someone with these findings, it can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the MYOC gene, the risk of open-angle glaucoma is mainly tied to the gene change itself and often rises with age. Steroid medicines can raise eye pressure in some people and may bring eye problems to light sooner. Regular eye pressure and optic nerve checks help catch changes early.
Inheritance of MYOC variants
MYOC-related glaucoma is usually inherited in an autosomal dominant pattern, which is the key point in understanding how MYOC gene variants are inherited. If you carry a disease-causing variant in the MYOC gene, each child has a 50% chance of inheriting that same variant. A parent of any sex can pass it on to a son or a daughter. Family members who inherit the variant may not all develop eye findings at the same age or with the same severity.
What does my MYOC result mean for my family?
For many living with a disease-causing MYOC change, the family pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change and may have a higher chance of developing glaucoma. Because of that, family members may want to discuss whether genetic testing is appropriate for them. Not everyone with a MYOC change is affected in exactly the same way or at the same age.
Genetic information
Genetic testing
How you find out about variants
To check for variants in the MYOC gene, a lab usually analyzes DNA from a blood or saliva sample. MYOC genetic testing for inherited glaucoma looks for spelling changes in the gene and can show whether you carry a variant linked to some forms of primary open-angle glaucoma.
When should I consider getting a genetic test?
Genetic testing for the MYOC gene may be worth considering if you or close family members have glaucoma, especially when it starts at a young age or appears in several generations. Finding a disease-causing MYOC variant can help explain inherited risk and may guide eye screening for relatives.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment can work well for one person, have little effect in another, or cause more side effects in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug acts and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MYOC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so questions about treatment, side effects, or eye health are best discussed with your doctor or eye specialist.
History
In the late 1990s, the MYOC gene became a turning point in glaucoma research. It was first identified in 1997 in studies of families with juvenile open angle glaucoma, and early reports referred to it as TIGR, short for trabecular meshwork inducible glucocorticoid response. Researchers had noticed that this eye condition could run in families, but this discovery gave scientists a clear genetic clue to follow. From these first observations, research expanded steadily. The gene was later renamed the MYOC gene, reflecting growing understanding of its role in inherited glaucoma. Its discovery helped establish glaucoma genetics as an important area of modern eye research.